Aktiesnakken — August 2012
-
ok. det er en is til den der finder ud af hvad der skete med velcade. Milenium/takeda buyout fra Celgene oder was?
-
men er casen ikke endnu bedre hvis Janssen ikke længere ejer Velcade
-
J&J har ihvertfald ejet noget af Velcade på et tiudspunkt. http://www.reuters.com/article/2010/11/19/us-jj-takeda-recall-idUSTRE6AI4IK20101119
-
jep. De vil alle have Dara.
-
It is sold by Millennium in the United States and by J&J unit Janssen-Cilag in Europe and the rest of the world.
-
deraf forvirringen.
-
Men Janssen laver vel ikke både duobody OG dara med Genmab??
-
i dont know :-)!
-
Jep. Håber ikke det bliver GSK
-
vil ikke være alt for afhængige af dem
-
men omvendt vil de give de bedste vilkår
-
mega emission i veloxis
-
0,35 pr. aktie
-
og udsætter maa til 2013
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind